The Association between Type 2 Diabetes Mellitus and Thyroid Cancer

Table 3

The effects of T2DM and T2DM medication on thyroid cancer.

	Adjusted^a		value	Adjusted^b		value
	OR	(95% CI)		OR	(95% CI)
T2DM versus no T2DM
Total (415 cases/415 controls)	0.71	(0.48–1.06)	0.091	0.70	(0.46–1.06)	0.092
Male (199 cases/199 controls)	0.97	(0.58–1.61)	0.896	1.00	(0.58–1.74)	0.991
Female (216 cases/216 controls)	0.45	(0.23–0.85)	0.014	0.40	(0.20–0.81)	0.011
T2DM medication versus no T2DM medication (50 cases/67 controls)	2.93	(1.27–6.76)	0.011	5.21	(1.58–17.15)	0.007

OR: odds ratio; CI: confidence interval; T2DM: type 2 diabetes mellitus. ^aAdjusted for matching variables (age and sex). ^bAdjusted for matching variables (age and sex), average monthly household income, education level, smoking status, alcohol intake, regular exercise, obesity, hypertension, dyslipidemia, ischemic heart disease, benign thyroid disease, and other cancers in T2DM versus no T2DM; adjusted for matching variables (age and sex), T2DM duration, average monthly household income, education level, smoking status, alcohol intake, regular exercise, obesity, hypertension, dyslipidemia, ischemic heart disease, benign thyroid disease, and other cancers in T2DM medication versus no T2DM medication.